Authors:
Niklinski, J
Niklinska, W
Chyczewski, L
Becker, HD
Pluygers, E
Citation: J. Niklinski et al., Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications, EUR J CAN P, 10(3), 2001, pp. 213-226
Authors:
Laudanski, J
Niklinska, W
Burzykowski, T
Chyczewski, L
Niklinski, J
Citation: J. Laudanski et al., Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer, EUR RESP J, 17(4), 2001, pp. 660-666
Citation: W. Niklinska et al., G1 phase of the cell cycle control and lung cancer: biological and clinical implications - Minireview, NEOPLASMA, 48(3), 2001, pp. 157-163
Authors:
Niklinska, W
Burzykowski, T
Chyczewski, L
Rusin, MR
Furman, M
Laudanski, J
Chyczewska, E
Sulik, M
Niklinski, J
Citation: W. Niklinska et al., p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland, EUR J CAN P, 9(2), 2000, pp. 81-87
Authors:
Gorski, J
Zendzian-Piotrowska, M
de Jong, YF
Niklinska, W
Glatz, JFC
Citation: J. Gorski et al., Effect of endurance training on the phospholipid content of skeletal muscles in the rat, EUR J A PHY, 79(5), 1999, pp. 421-425
Authors:
Niklinski, J
Burzykowski, T
Niklinska, W
Laudanski, J
Chyczewski, L
Rapellino, M
Furman, M
Citation: J. Niklinski et al., Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer, EUR RESP J, 12(6), 1998, pp. 1424-1428
Authors:
Laudanski, J
Burzykowski, T
Niklinska, W
Chyczewski, L
Furman, M
Niklinski, J
Citation: J. Laudanski et al., Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer, LUNG CANC, 22(3), 1998, pp. 191-200